Drug
Nabiximols
Nabiximols: highest development phase Phase 3, developed by Jazz Pharmaceuticals. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nabiximols NCT04984278 | Phase 3 | Spasticity With Multiple Sclerosis |
| Nabiximols NCT01424566 | Phase 3 | Pain |
| Nabiximols NCT01361607 | Phase 3 | Pain |
Latest
No recent events.
Follow Nabiximols on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.